IGF-I Receptor Mutations Resulting in Intrauterine and Postnatal Growth Retardation

New England Journal of Medicine

Volumn 349, Issue 23, 2003, Pages 2211-2222

  Abuzzahab, M Jennifer ^a   Schneider, Anke ^b   Goddard, Audrey ^c   Grigorescu, Florin ^d   Lautier, Corinne ^d   Keller, Eberhard ^b   Kiess, Wieland ^b   Klammt, Jürgen ^b   Kratzsch, Jürgen ^b   Osgood, Doreen ^e   Pfäffle, Roland ^b   Raile, Klemens ^b   Seidel, Berthold ^b   Smith, Robert J ^e   Chernausek, Steven D ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c GENENTECH INC   (United States)

^d UNIV MONTPELLIER   (France)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN C RECEPTOR;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; FIBROBLAST; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GROWTH RETARDATION; HETEROZYGOSITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MALE; NONSENSE MUTATION; POINT MUTATION; POSTNATAL GROWTH; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SHORT STATURE; SINGLE STRAND CONFORMATION POLYMORPHISM;

AMINO ACID SEQUENCE; CELLS, CULTURED; CHILD, PRESCHOOL; CODON, NONSENSE; COHORT STUDIES; FEMALE; FETAL GROWTH RETARDATION; FIBROBLASTS; GROWTH DISORDERS; HETEROZYGOTE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PEDIGREE; PHOSPHORYLATION; POINT MUTATION; RECEPTOR, IGF TYPE 1;

EID: 0344874656     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa010107     Document Type: Article

References (32)

1. Abbott AM, Bueno R, Pedrini MT, Murray JM, Smith RJ. Insulin-like growth factor I receptor gene structure. J Biol Chem 1992;267:10759-63.
2. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995;16:143-63.
3. Tritos NA, Mantzoros CS. Clinical review 97: syndromes of severe insulin resistance. J Clin Endocrinol Metab 1998;83:3025-30.
4. Accili D. Molecular defects of the insulin receptor gene. Diabetes Metab Rev 1995;11:47-62.
5. Bierich JR, Moeller H, Ranke MB, Rosenfeld RG. Pseudopituitary dwarfism due to resistance to somatomedin: a new syndrome. Eur J Pediatr 1984;142:186-8.
6. Heath-Monning E, Wohltmann HJ, Mills-Dunlap B, Daughaday WH. Measurement of insulin-like growth factor-I (IGF-I) responsiveness of fibroblasts of children with short stature: identification of a patient with IGF-1 resistance. J Clin Endocrinol Metab 1987;64:501-7.
7. Momoi T, Yamanaka C, Kobayashi M, et al. Short stature with normal growth hormone and elevated IGF-I. Eur J Pediatr 1992;151:321-5.
8. Hattori Y, Vera JC, Rivas CI, et al. Decreased insulin-like growth factor I receptor expression and function in immortalized African Pygmy T cells. J Clin Endocrinol Metab 1996;81:2257-63.
9. Roback EW, Barakat AJ, Dev VG, Mbikay M, Chrétien M, Butler MG. An infant with deletion of the distal long arm of chromosome 15 (q26.1→qter) and loss of insulin-like growth factor 1 receptor gene. Am J Med Genet 1991;38:74-9.
10. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor (Igf-1) and the type 1 IGF receptor (Igf1r). Cell 1993;75:59-72.
11. Kiess W, Gausche R, Keller A, Burmeister J, Willgerodt H, Keller E. Computer-guided, population-based screening system for growth disorders (CrescNet) and on-line generation of normative data for growth and development. Horm Res 2001;56:Suppl 1:59-66.
12. Sandford AJ, Pare PD. Direct PCR of small genomic DNA fragments from serum. Biotechniques 1997;23:890-2.
13. Glavac D, Dean M. Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat 1993;2:404-14.
14. McCusker RH, Camacho-Hubner C, Bayne ML, Cascieri MA, Clemmons DR. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol 1990;144:244-53.
15. Orlowski CC, Chernausek SD, Akeson R. Actions of insulin-like growth factor-I on the B104 neuronal cell line: effects on cell replication, receptor characteristics, and influence of secreted binding protein on ligand binding. J Cell Physiol 1989;139:469-76.
16. Chow JC, Condorelli G, Smith RJ. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J Biol Chem 1998;273:4672-80.
17. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Advance data from vital and health statistics. No. 314. Hyattsville, Md.: National Center for Health Statistics, 2000. (DHHS publication no. (PHS) 2000-1250 0-0431.)
18. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, Calif.: Stanford University Press, 1959.
19. Zadik Z, Chalew SA, Kowarski A. Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation. J Clin Endocrinol Metab 1990;71:932-6.
20. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Shakkebaek NE. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf) 1994;41:85-93.
21. Largo RH, Walli P, Duc G, Fanconi A, Prader A. Evaluation of perinatal growth: presentation of combined intra- and extra-uterine growth standards for weight, length and head circumference. Helv Paediatr Acta 1980;35:419-36.
22. Prader A, Largo RH, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age: First Zurich Longitudinal Study of growth and development. Helv Paediatr Acta Suppl 1989;52:1-125.
23. Garrett TP, McKern NM, Lou M, et al. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Nature 1998;394:395-9.
24. Hone J, Accili D, al-Gazali LI, Lestringant G, Orban T, Taylor SI. Homozygosity for a new mutation (Ile119→Met) in the insulin receptor gene in five sibs with familial insulin resistance. J Med Genet 1994;31:715-6.
25. Peoples R, Milatovich A, Francke U. Hemizygosity at the insulin-like growth factor I receptor (IGF1R) locus and growth failure in the ring chromosome 15 syndrome. Cytogenet Cell Genet 1995;70:228-34.
26. Geffner ME, Bailey RC, Bersch N, Vera JC, Golde DW. Insulin-like growth factor-I unresponsiveness in an Efe Pygmy. Biochem Biophys Res Commun 1993;193:1216-23.
27. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994;15:369-90.
28. Woods KA, Camacho-Hübner C, Savage MO, Clark AJL. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996;335:1363-7.
29. Blagitko N, Mergenthaler S, Schulz U, et al. Human GRB10 is imprinted and expressed from the paternal and maternal allele in a highly tissue- and isoform-specific fashion. Hum Mol Genet 2000;9:1587-95.
30. Howard TK, Algar EM, Glatz JA, Reeve AE, Smith PJ. The insulin-like growth factor 1 receptor gene is normally biallelically expressed in human juvenile tissue and tumours. Hum Mol Genet 1993;2:2089-22.
31. Ogawa O, Eccles MR, Szeto J, et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993;362:749-51.
32. D'Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 1996;13:227-55.